Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?Gilead's lenacapavir shows exceptional efficacy in preventing HIV and is a potential game-changer in the global fight against AIDS.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor CountriesGilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%Lenacapavir, a twice-yearly injectable, is shown to be more effective than Truvada in preventing HIV in recent clinical trials.
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?Gilead's lenacapavir shows exceptional efficacy in preventing HIV and is a potential game-changer in the global fight against AIDS.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor CountriesGilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
Biotech giant Gilead lays off 104 from Bay Area HQ, including execsGilead Sciences is reducing its workforce amid a strategic reallocation of resources for future product launches.
Gilead Alleges HIV Medication Counterfeiting Operation in NYC PharmaciesGilead Sciences is suing a medical defrauder and pharmacies for selling counterfeit HIV medications, endangering patient health and safety.
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuitA drug-counterfeiting operation involving Gilead's HIV medications was uncovered, exposing patients to serious health risks.Peter Khaim is identified as the mastermind behind the counterfeit drugs sold through two pharmacies in NYC.
Gilead Alleges HIV Medication Counterfeiting Operation in NYC PharmaciesGilead Sciences is suing a medical defrauder and pharmacies for selling counterfeit HIV medications, endangering patient health and safety.
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuitA drug-counterfeiting operation involving Gilead's HIV medications was uncovered, exposing patients to serious health risks.Peter Khaim is identified as the mastermind behind the counterfeit drugs sold through two pharmacies in NYC.